Adam Maeder
Stock Analyst at Piper Sandler
(2.96)
# 1,194
Out of 5,182 analysts
104
Total ratings
40.26%
Success rate
1.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Overweight | $620 → $580 | $466.64 | +24.29% | 23 | Apr 22, 2026 | |
| ABT Abbott Laboratories | Maintains: Overweight | $135 → $115 | $93.86 | +22.52% | 5 | Apr 17, 2026 | |
| RXST RxSight | Maintains: Neutral | $11 → $10 | $7.17 | +39.47% | 4 | Feb 26, 2026 | |
| TCMD Tactile Systems Technology | Maintains: Overweight | $35 → $42 | $23.57 | +78.19% | 6 | Feb 18, 2026 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $165 → $85 | $55.11 | +54.24% | 18 | Feb 12, 2026 | |
| EW Edwards Lifesciences | Reiterates: Overweight | $98 → $100 | $82.28 | +21.54% | 19 | Feb 11, 2026 | |
| RMD ResMed | Maintains: Neutral | $270 → $275 | $217.14 | +26.65% | 5 | Jan 30, 2026 | |
| SGHT Sight Sciences | Upgrades: Overweight | $5 → $9 | $4.36 | +106.42% | 3 | Jan 5, 2026 | |
| NYXH Nyxoah | Reiterates: Overweight | $12 → $9 | $3.01 | +199.00% | 9 | Nov 14, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $1.14 | +250.88% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $19.43 | +8.08% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $1.64 | +387.80% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $1.86 | +168.82% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $61.29 | +61.53% | 3 | May 5, 2022 |
Intuitive Surgical
Apr 22, 2026
Maintains: Overweight
Price Target: $620 → $580
Current: $466.64
Upside: +24.29%
Abbott Laboratories
Apr 17, 2026
Maintains: Overweight
Price Target: $135 → $115
Current: $93.86
Upside: +22.52%
RxSight
Feb 26, 2026
Maintains: Neutral
Price Target: $11 → $10
Current: $7.17
Upside: +39.47%
Tactile Systems Technology
Feb 18, 2026
Maintains: Overweight
Price Target: $35 → $42
Current: $23.57
Upside: +78.19%
Inspire Medical Systems
Feb 12, 2026
Maintains: Overweight
Price Target: $165 → $85
Current: $55.11
Upside: +54.24%
Edwards Lifesciences
Feb 11, 2026
Reiterates: Overweight
Price Target: $98 → $100
Current: $82.28
Upside: +21.54%
ResMed
Jan 30, 2026
Maintains: Neutral
Price Target: $270 → $275
Current: $217.14
Upside: +26.65%
Sight Sciences
Jan 5, 2026
Upgrades: Overweight
Price Target: $5 → $9
Current: $4.36
Upside: +106.42%
Nyxoah
Nov 14, 2025
Reiterates: Overweight
Price Target: $12 → $9
Current: $3.01
Upside: +199.00%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $1.14
Upside: +250.88%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $19.43
Upside: +8.08%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.64
Upside: +387.80%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $1.86
Upside: +168.82%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $61.29
Upside: +61.53%